Cancer Care & Hematology Specialists of Chicagoland — Niles, Illinois

Cancer Care & Hematology Specialists of Chicagoland is a clinical research site located in Niles, Illinois, United States 60714.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

Cancer Care & Hematology Specialists of Chicagoland has participated in 19 clinical trials.

Therapeutic areas: Breast Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma.

Sponsors: NSABP Foundation Inc, Genentech, Inc., US Oncology Research.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Niles

Browse all research sites in Illinois · View every site in Niles

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cancer Care & Hematology Specialists of Chicagoland?

Cancer Care & Hematology Specialists of Chicagoland has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cancer Care & Hematology Specialists of Chicagoland conducted?

Cancer Care & Hematology Specialists of Chicagoland has 19 clinical trials on record. Their work covers Breast Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma.

Is Cancer Care & Hematology Specialists of Chicagoland accredited by Crixeo Clinical Trials?

Cancer Care & Hematology Specialists of Chicagoland has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cancer Care & Hematology Specialists of Chicagoland?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.